Literature DB >> 191326

Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats.

K Okita, K Noda, Y Fukumoto, T Takemoto.   

Abstract

Amount of cytochrome P-450 in the hyperplastic liver nodules was measured during hepatocarcinogenesis with N-2-fluorenylacetamide in the rat. Amount of cytochrome P-450 in the liver microsome decreased in early stage of hepatocarcinogenesis. Concentration of cytochrome P-450 in the hyperplastic nodules and their surrounding tissues was examined, using homogenate from each of them. Its amount was significantly less in the hyperplastic nodules in the 13th week than in their surrounding tissues, and became more in hyperplastic nodules in the 19th week. The hyperplastic nodules of the animals treated with phenobarbital showed almost the same amount of cytochrome P-450 as that in the controls. Amount of cytochrome P-450 in hepatoma tissues also showed similar values as that in hyperplastic nodules.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 191326

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  12 in total

1.  Regulation of glutathione transferase and DT-diaphorase mRNAs in persistent hepatocyte nodules during chemical hepatocarcinogenesis.

Authors:  C B Pickett; J B Williams; A Y Lu; R G Cameron
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

2.  Newer insights into the pathogenesis of liver cancer.

Authors:  E Farber; D Solt; R Cameron; B Laishes; K Ogawa; A Medline
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307

3.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

4.  The lipid composition of highly differentiated human hepatomas, with special reference to fatty acids.

Authors:  I Eggens; L Bäckman; A Jakobsson; C Valtersson
Journal:  Br J Exp Pathol       Date:  1988-10

5.  Profile of drug metabolizing enzymes in the nuclear and microsomal fractions from rat liver nodules and normal liver.

Authors:  G M Pacifici; L C Eriksson; H Glaumann; A Rane
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

6.  Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

Authors:  K H Cowan; G Batist; A Tulpule; B K Sinha; C E Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 7.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcinogenesis.

Authors:  H W Kunz; A Buchmann; M Schwarz; R Schmitt; W D Kuhlmann; C R Wolf; F Oesch
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

9.  Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis.

Authors:  L Eriksson; M Ahluwalia; J Spiewak; G Lee; D S Sarma; M J Roomi; E Farber
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

10.  Association between responsiveness to phenobarbital induction of CYP2B1/2 and 3A1 in rat hepatic hyperplastic nodules and their zonal origin.

Authors:  Z Y Chen; D L Eaton
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.